Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(15):1170-1171; doi:10.1093/jnci/djg006
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Trimbos, J. B.
Right arrow Articles by Vergote, I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Trimbos, J. B.
Right arrow Articles by Vergote, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Cancer

J. Baptist Trimbos, Ignace Vergote
On Behalf of the EORTC–ACTION Collaborators

Affiliations of authors: J. B. Trimbos, Leiden University Medical Center, Leiden, The Netherlands; I. Vergote, University Hospitals, Leuven, Belgium.

Correspondence to: J. Baptist Trimbos, MD, Ph.D., Department of Gynecology, Leiden University Medical Center, POB 9600, 2300 RC, Leiden, The Netherlands (e-mail: J.B.M.Z.Trimbos@lumc.nl).

The first 10% of the full text of this article appears below.

We thank Dr. Green for his compliments regarding the publication of the European Organisation for Research and Treatment of Cancer (EORTC)–Adjuvant ChemoTherapy In Ovarian Neoplasm (ACTION) trial (1). Nevertheless, there are a number of comments with which we disagree.

Dr. Green supports the notion that the benefit of adjuvant chemotherapy is important enough to influence clinical decision making based on the overall and recurrence-free survival results of the combined analysis of the ACTION and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?